Biomedical Engineering Reference
In-Depth Information
Kushwaha AK, Vuddanda PR, Karunanidhi P, Singh SK, Singh S (2013) Development and eval-
uation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.
Biomed Res Int 2013:584549-584557
Kwon GS, Suwa S, Yokoyama M, Okano T, Saurai Y, Kataoka K (1994) Enhanced tumoraccu-
mulation and prolonged circulation times of micelle-forming poly(ethylene oxideaspartate)
block copolymer adriamycin conjugates. J Control Release 29:17-23
Kwon HS, Jung SG, Kim HY, Parker SA, Batt CA, Kim YR (2014) A multi-functional polyhy-
droxybutyrate nanoparticle for theranostic applications. J Mater Chem B 2:3965-3971
Kyung HM, Kyeongsoon P, Yoo-Shin K, Sang MB, Seulki L (2008) Hydrophobically modi-
fied glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and
tumor targeting in cancer therapy. J Control Release 127:208-218
Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G (2009) New strategies to
deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv 6:1017-1032
Lau S, Graham B, Cao N, Boyd BJ, Pouton CW, White PJ (2012) Enhanced extravasation, stabil-
ity and in vivo cardiac gene silencing via in situ siRNA
−
albumin conjugation. Mol Pharm
9:71-80
Lee SJ, Koo H, Jeong H, Huh MS, Choi Y, Jeong SY, Byun Y, Choi K, Kim K, Kwon IC (2011)
Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for
cancer therapy. J Control Release 152:21-29
Lee BS, Park K, Park S, Kim GC, Kim HJ, Lee S, Kil H, Oh SJ, Chi D, Kim K, Choi K, Kwon
IC, Kim SY (2010) Tumor targeting efficiency of bare nanoparticles does not mean the
efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization
of highly selective tumor targeting polymeric nanoparticles with or without drug. J Control
Release 147(2):253-260
Lee CC, Gillies ER, Fox ME, Guillaudeu SJ, Frechet JMJ, Dy EE, Szoka FC (2006) A single
dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon
carcinomas. Proc Natl Acad Sci USA 103:16649-16654
Lee CC, MacKay JA, Frechet JMJ, Szoka FC (2005) Designing dendrimers for biological
applications. Nat Biotechnol 23:1517-1526
Lee CH, Rajendran R, Jeong MY, Ko HY, Joo JY, Cho S, Chang YK, Kim S (2013) Bioimaging
of targeting cancers using aptamer-conjugated carbon nanodots. Chem Commun
49:6345-6543
Lee M-S, Jung J-I, Kwon S-H, Lee S-M, Morita K, Her S (2012) TIMP-2 fusion protein with
human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by
suppressing MMP-2 expression. PLoS ONE 7:e35710
Lee MS, Kim YH, Kim YJ, Kwon SH, Bang JK, Lee SM, Song YS, Hahm DH, Shim I, Han D,
Her S (2011) Pharmacokinetics and biodistribution of human serum albumin-TIMP-2 fusion
protein using near-infrared optical imaging. J Pharm Pharm Sci 14:368-377
Lee S, Koo H, Na JH, Han SJ, Min HS, Lee SJ, Kim SH, Yun SH, Jeong SY, Kwon IC, Choi K,
Kim K (2014) Chemical tumor-targeting of nanoparticles based on metabolic glycoengineer-
ing and click chemistry. ACS Nano 8(3):2048-2063
Lee T, Zhang X, Dhar S, Faas H, Lippard SJ, Jasanoff A (2010) In vivo imaging with a cell-
permeable porphyrin-based MRI contrast agent. Chem Biol 17:665-673
Li C, Xing L, Che S (2012) Coordination bonding based pH-responsive albumin nanoparticles
for anticancer drug delivery. Dalton Trans 41:3714-3719
Li CC, Chi JL, Ma Y, Li JH, Xia CQ, Li L, Chen Z, Chen XL (2014) Interventional therapy for
human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following
intratumoral injection. Radiat Oncol 9:144
Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS (2012)
Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm
10:329-336 (2013)
